(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 8.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.8%.
Boston Scientific's revenue in 2025 is $19,350,000,000.On average, 36 Wall Street analysts forecast BSX's revenue for 2026 to be $33,489,848,103,049, with the lowest BSX revenue forecast at $32,080,045,723,960, and the highest BSX revenue forecast at $37,135,173,076,950. On average, 31 Wall Street analysts forecast BSX's revenue for 2027 to be $37,003,235,735,479, with the lowest BSX revenue forecast at $35,310,286,926,941, and the highest BSX revenue forecast at $39,351,423,925,255.
In 2028, BSX is forecast to generate $40,590,745,469,859 in revenue, with the lowest revenue forecast at $38,768,824,203,928 and the highest revenue forecast at $43,220,597,647,045.